Research & Development

Gilead and Vir Partner on $1.74 Billion Cancer Therapy Deal
Research & Development Gilead and Vir Partner on $1.74 Billion Cancer Therapy Deal

The pursuit of a definitive cure for solid tumors has long been hindered by a biological paradox where the very therapies designed to annihilate malignant cells often end up inflicting severe damage on healthy tissues. This persistent struggle with toxicity has left many promising immunotherapies

How Can the PSRM Ensure Ethical Regenerative Medicine?
Research & Development How Can the PSRM Ensure Ethical Regenerative Medicine?

A primary mission for the PSRM involves dismantling the 'magic bullet' myth by clarifying that regenerative medicine is a multifaceted field focused on long-term biological restoration. The Philippine Society of Regenerative Medicine (PSRM) was established at a pivotal moment in the nation's

Will Clinical Success Drive Regeneron to New Heights?
Research & Development Will Clinical Success Drive Regeneron to New Heights?

A massive capital infusion from Sixth Street Partners, which added over 846,000 shares, signals a strong bet on the next phase of Regeneron’s medical pipeline. This institutional confidence arrives as the biotechnology giant demonstrates remarkable clinical prowess, particularly with its latest

Can Metabolism Boost the Immune Fight Against Colon Cancer?
Research & Development Can Metabolism Boost the Immune Fight Against Colon Cancer?

Enhancing the fat-burning capabilities of CAR T cells allows these engineered immune units to penetrate and kill solid tumor cells more effectively. This development arrives as colorectal cancer has transitioned into the leading cause of cancer-related mortality for adults under the age of 50. The

CHOP Researchers Link MAP2K4 Gene to Rare Brain Disorder
Research & Development CHOP Researchers Link MAP2K4 Gene to Rare Brain Disorder

Investigating the Genetic Basis of Neurodevelopmental Disorders The diagnostic journey for families navigating the complex intricacies of unexplained pediatric neurological conditions often spans years of agonizing uncertainty while they wait for a molecular answer that may never materialize. This

How Will PrimeStack Revolutionize Large-Scale Gene Editing?
Research & Development How Will PrimeStack Revolutionize Large-Scale Gene Editing?

Using junction-specific PCR analyses, researchers confirmed that PrimeStack can achieve success rates that are significantly higher than traditional targeted insertion methods. This breakthrough addresses a challenge that has frustrated plant scientists for decades: the extreme difficulty of

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later